Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4/A Exercise or conversion Director acquired 1,030 shares (option exercise)
  5. 4/A Exercise or conversion Director acquired 47,999 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 2,211 shares (option exercise)
  7. 4 Exercise or conversion Chief Executive Officer acquired 18,333 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale General Counsel sold 1,636 shares at $10.12 ($16,556)
  10. 4 Open-market sale Chief Medical Officer sold 1,900 shares at $10.12 ($19,228)
  11. 4 Exercise or conversion Chief Medical Officer acquired 122,677 shares (option exercise)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Chief Medical Officer sold 258 shares at $11.85 ($3,057)
  15. 4 Exercise or conversion Director acquired 47,999 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 160,000 shares (option exercise)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Exercise or conversion Director acquired 3,241 shares (option exercise)
  20. 4 Open-market sale General Counsel sold 3,606 shares at $7.21 ($25,999)

Page 5 of 12 · 233 filings